2021
DOI: 10.1016/j.bbrc.2020.10.109
|View full text |Cite
|
Sign up to set email alerts
|

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
101
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(107 citation statements)
references
References 21 publications
3
101
0
1
Order By: Relevance
“…Recently, SARS-CoV-2 isolates with the D614G mutation in the S protein were described [ 13 , 19 - 22 ]. Over a short period of time, those mutant variants have gained dominance in many areas where they were found.…”
Section: Hypothesis and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, SARS-CoV-2 isolates with the D614G mutation in the S protein were described [ 13 , 19 - 22 ]. Over a short period of time, those mutant variants have gained dominance in many areas where they were found.…”
Section: Hypothesis and Discussionmentioning
confidence: 99%
“…It was demonstrated that the D614G mutation decreases the stability of the S protein trimer and facilitates RBD transition into its open conformation [ 23 ]. This mutation increases the overall virus infectivity and fitness [ 19 - 22 , 24 ], increases affinity of furin binding to the S protein [ 25 ], and promotes viral replication [ 26 ]. However, there are no indications that the D614G mutation is associated with more severe COVID-19 infection symptoms.…”
Section: Hypothesis and Discussionmentioning
confidence: 99%
“…For example, the common mutation D614G on the S protein may increase binding affinity between the S protein and host ACE2 receptor, thus enhancing virus loads which lead to increased infectivity. Although the mutation does not change the ability of antibody recognition, the G-form variant is more readily neutralized by a human antibody [33] . By investigating 80 mutants and 26 modifications of the glycosylation site on the S protein, Li et al [34] found that several mutants, including A475V, L452R, V483A, and F490L increased their resistance to neutralizing antibodies and deletion of glycosylation sites N331 and N343 decreased viral infectivity.…”
Section: Genetic Mutations Of Sars-cov-2mentioning
confidence: 96%
“…Structure and function (genomic/proteomic) comparison of nsp14 and nsp10 (independently and in complex) between sister clades of SARS-CoV-2 variants (D614G 488,489 , N501Y 490 , etc. 491 ) may offer clues, if we can identify specific mutations in the parent genome which affected nsp14 (exoribonuclease for proofreading) and/or nsp10, resulting in progeny which causes more harm.…”
Section: Appendix IV -Aptamers As Adjuvants And/or Parallel Alternatimentioning
confidence: 99%